LY
Lyka Labs Limited
LYKALABS.BO · BSE
₹80.86 -2.00% (-₹1.65)
1M +21.55%
Market Cap ₹3.00B
P/E Ratio -
Div. Yield -
ROE 8.93%
Bulios Fair Price
₹43.18
46.6% downside
Trenutna cena
₹80.86
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LYKALABS.BO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
30 /100
Expensive P/S 2.18x
P/FCF 58.26x
P/B 3.24x
Growth
81 /100
Growing Rev. growth 11.89%
Book val. growth 26.69%
EPS growth N/A
Profitability
16 /100
Weak Gross margin 22.63%
FCF margin 3.74%
Net margin 6.46%
Quality
10 /100
Poor ROIC 6.39%
Asset turnover 0.79x
ROE 8.93%
Debt
48 /100
Moderate Debt/Equity 0.53x
Int. coverage -2.68x
Current ratio 1.17x
Stability
16 /100
Unstable Beta 0.16x
Profitable years 0
Rev. volatility 21.33%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LYKALABS.BO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kunal Narendra Gandhi
Employees
648
Headquarters
Mumbai